Damora Therapeutics, Inc. · NASDAQ:DMRA
Jarrett Jennifer received 500,000 Damora Therapeutics, Inc. shares as an award (Form 4)
Traded Mar 30, 2026 · Filed Apr 1, 2026
On Mar 30, 2026, Jarrett Jennifer (Director, See Remarks) received 500,000 Damora Therapeutics, Inc. shares as an award, leaving 500,000 shares. Filed Apr 1, 2026 (Form 4).
- Awarded
- 500,000 shares
- Holding after
- 500,000 shares
- Trading plan
- No
- Role
- Director, See Remarks
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Mar 30, 2026 | Common Stock | Award | 500,000 | 500,000 | Direct |
Source
Related
- Damora Therapeutics, Inc.
- Jarrett Jennifer
- Damora Therapeutics, Inc. shareholders
- Form 4 · Jarrett Jennifer · Sep 28, 2026
- Schedule 13G · BlackRock, Inc. · Jul 28, 2026
- Form 4 · Winslow Garrett · Jul 7, 2026
- Schedule 13G · Avoro Capital Advisors LLC · May 15, 2026
- Schedule 13G/A · Jain Global LLC · May 15, 2026
- Schedule 13G/A · Point72 Asset Management, L.P. · May 15, 2026